Literature DB >> 16096818

Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.

Arnaud Delval1, Pierre Krystkowiak, Jean-Louis Blatt, Etienne Labyt, Kathy Dujardin, Alain Destée, Philippe Derambure, Luc Defebvre.   

Abstract

OBJECTIVE: To evaluate specific patterns of locomotion in Huntington's disease (HD) and notably the respective roles of hypokinesia (i. e. a decrease in the amplitude of movement) and bradykinesia (i. e. difficulty in executing a movement, slowness) in gait disturbance.
METHODS: Kinematic, spatial (stride length, speed), temporal (cadence, speed, and stride time) and angular gait parameters (joint ankle range) were recorded in 15 early-stage HD patients by means of a video motion analysis system and then compared with 15 controls and 15 Parkinson's disease (PD) patients. Hypokinesia was studied in terms of both spatial (decrease in stride length) and angular gait parameters (decrease in joint ankle range), whereas hyperkinesia was characterized by an increase in joint ankle range. Bradykinesia (defined by a decrease in gait velocity) was also assessed in terms of temporal parameters (cadence, stride time). We studied the influence of clinical symptoms (motor dysfunction, chorea, overall disability and cognitive impairment) and the CAG repeat number on gait abnormalities.
RESULTS: we observed a clear decrease in gait speed, a decrease in cadence and an increase in stride time (i. e. bradykinesia) for HD, with significant intra-individual variability. Cadence remained normal in PD. In HD, there was no evidence for a clear decrease in stride length, although the latter is a characteristic feature of hypokinetic gait (such as that observed in PD). Angle analysis revealed the coexistence of hyperkinesia and hypokinesia in HD, which thus participate in gait abnormalities. Gait speed in HD was correlated to the motor part of the UHDRS.
CONCLUSION: Gait in HD is mainly characterized by a timing disorder: bradykinesia was present, with severe intra-individual variability in temporal gait parameters.

Entities:  

Mesh:

Year:  2005        PMID: 16096818     DOI: 10.1007/s00415-005-0929-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Chronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system.

Authors:  P Krystkowiak; J L Blatt; J L Bourriez; A Duhamel; M Perina; G Kemoun; S Blond; J D Guieu; A Destée; L Defebvre
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

Review 2.  The functional anatomy of disorders of the basal ganglia.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1995-02       Impact factor: 13.837

3.  Postural and gait disturbance correlated with decreased frontal cerebral blood flow in Alzheimer disease.

Authors:  T Nakamura; K Meguro; H Yamazaki; H Okuzumi; A Tanaka; A Horikawa; K Yamaguchi; N Katsuyama; M Nakano; H Arai; H Sasaki
Journal:  Alzheimer Dis Assoc Disord       Date:  1997-09       Impact factor: 2.703

4.  Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.

Authors:  J B Penney; A B Young; I Shoulson; S Starosta-Rubenstein; S R Snodgrass; J Sanchez-Ramos; M Ramos-Arroyo; F Gomez; G Penchaszadeh; J Alvir
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

5.  Effects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease.

Authors:  Pierre Krystkowiak; Jean-Louis Blatt; Jean-Louis Bourriez; Alain Duhamel; Miriam Perina; Serge Blond; Jean-Daniel Guieu; Alain Destée; Luc Defebvre
Journal:  Arch Neurol       Date:  2003-01

6.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Postural stability in patients with Huntington's disease.

Authors:  J Tian; S J Herdman; D S Zee; S E Folstein
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

8.  The pathogenesis of gait hypokinesia in Parkinson's disease.

Authors:  M E Morris; R Iansek; T A Matyas; J J Summers
Journal:  Brain       Date:  1994-10       Impact factor: 13.501

9.  Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia.

Authors:  R L Albin; A Reiner; K D Anderson; J B Penney; A B Young
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

10.  Huntington's disease: clinical correlates of disability and progression.

Authors:  N Mahant; E A McCusker; K Byth; S Graham
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

View more
  12 in total

Review 1.  "Pre-symptomatic" Huntington's disease.

Authors:  Kevin Duff; Leigh J Beglinger; Jane S Paulsen
Journal:  Handb Clin Neurol       Date:  2008

2.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

3.  Impaired motor speech performance in Huntington's disease.

Authors:  Sabine Skodda; Uwe Schlegel; Rainer Hoffmann; Carsten Saft
Journal:  J Neural Transm (Vienna)       Date:  2013-11-13       Impact factor: 3.575

4.  Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.

Authors:  Stephen C Fowler; Nancy A Muma
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

5.  Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.

Authors:  João Casaca-Carreira; Yasin Temel; Marloes van Zelst; Ali Jahanshahi
Journal:  Behav Neurol       Date:  2015-05-06       Impact factor: 3.342

6.  Gait in Huntington's disease and the stride length-cadence relationship.

Authors:  Mary Danoudis; Robert Iansek
Journal:  BMC Neurol       Date:  2014-10-01       Impact factor: 2.474

7.  A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.

Authors:  Emma Yhnell; Stephen B Dunnett; Simon P Brooks
Journal:  J Huntingtons Dis       Date:  2016-05-31

8.  Quantitative Gait Analysis in Patients with Huntington's Disease.

Authors:  Seon Jong Pyo; Hanjun Kim; Il Soo Kim; Young-Min Park; Mi-Jung Kim; Hye Mi Lee; Seong-Beom Koh
Journal:  J Mov Disord       Date:  2017-08-31

9.  Three-Dimensional Trunk and Lower Limbs Characteristics during Gait in Patients with Huntington's Disease.

Authors:  Elzbieta Mirek; Magdalena Filip; Wiesław Chwała; Krzysztof Banaszkiewicz; Monika Rudzinska-Bar; Jadwiga Szymura; Szymon Pasiut; Andrzej Szczudlik
Journal:  Front Neurosci       Date:  2017-10-12       Impact factor: 4.677

10.  Gait variability as digital biomarker of disease severity in Huntington's disease.

Authors:  Heiko Gaßner; Dennis Jensen; F Marxreiter; Anja Kletsch; Stefan Bohlen; Robin Schubert; Lisa M Muratori; Bjoern Eskofier; Jochen Klucken; Jürgen Winkler; Ralf Reilmann; Zacharias Kohl
Journal:  J Neurol       Date:  2020-02-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.